Breaking News Instant updates and real-time market news.

AMRN

Amarin

$19.41

0.645 (3.44%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55

Amarin management to meet with Jefferies

Meeting to be held in Kansas City, MO on June 19 hosted by Jefferies.

  • 19

    Jun

  • 28

    Sep

AMRN Amarin
$19.41

0.645 (3.44%)

05/02/19
SBSH
05/02/19
NO CHANGE
Target $23
SBSH
Buy
Amarin selloff creates attractive entry point, says Citi
Citi analyst Joel Beatty believes the selloff yesterday in shares of Amarin (AMRN) brings an attractive entry point. He raised his price target for the stock to $23 from $20 and keeps a Buy rating on the name. The analyst sees five potential upside catalysts this year, including a likely supportive ICER cost-effectiveness review and potential priority review from the FDA. Further, while an acquisition of Amarin is possible, the company acquiring The Medicines Co. (MDCO) or Esperion (ESPR) "could also be a viable path," says Beatty.
05/17/19
BTIG
05/17/19
INITIATION
Target $5
BTIG
Buy
Matinas BioPharma initiated with a Buy at BTIG
BTIG analyst Robert Hazlett initiated Matinas BioPharma (MTNB) with a Buy rating and $5 price target, noting that the company's lead candidate, MAT9001, showed superior TG lowering versus Amarin's(AMRN) Vascepa. He thinks the Omega 3 class can have multiple winners and estimates MAT9001 peak revenue of greater than $2B.
05/29/19
CANT
05/29/19
NO CHANGE
Target $35
CANT
Overweight
Amarin Priority Review could drive upside to estimates, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen says that because of this morning's Priority Review designation, the timing of the FDA action date for Vascepa is four months earlier than the anticipated standard ten-month review for applications. Amarin had been assuming a standard ten-month review, and so has the Street, Chen tells investors in a research note. As such, she believes this morning's news, as well as the "positive" year-over-year prescription trends could drive upside to consensus estimates in 2019 and beyond. The analyst keeps an Overweight rating on Amarin shares with a $35 price target.
06/17/19
ROTH
06/17/19
INITIATION
Target $31
ROTH
Buy
Amarin initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started coverage of Amarin with a Buy rating and $31 price target. While it has gained $4.7B valuation in last nine months and investors may think they have missed the boat to invest in Amarin, the analyst disagrees with this outlook and views sNDA as the gatekeeper for M&A, soon to be open.

TODAY'S FREE FLY STORIES

OEC

Orion Engineered

$18.41

0.05 (0.27%)

17:33
07/22/19
07/22
17:33
07/22/19
17:33
Hot Stocks
Orion Engineered announces price increases »

Orion Engineered Carbons…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 06

    Aug

HMST

HomeStreet

$27.76

-0.03 (-0.11%)

17:31
07/22/19
07/22
17:31
07/22/19
17:31
Earnings
HomeStreet reports Q2 core EPS 13c, consensus 52c »

"The second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

GLD

SPDR Gold Shares

$134.46

(0.00%)

17:31
07/22/19
07/22
17:31
07/22/19
17:31
Hot Stocks
SPDR Gold Shares holdings rise to 825.18MT from 820.49MT »

This is the 4th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$36.01

2.42 (7.20%)

17:29
07/22/19
07/22
17:29
07/22/19
17:29
Syndicate
RA Pharmaceuticals files to sell $100M of common stock »

Jefferies, BMO Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHE

Benchmark Electronics

$25.05

0.22 (0.89%)

17:29
07/22/19
07/22
17:29
07/22/19
17:29
Hot Stocks
Benchmark Electronics appoints Rob Crawford Chief Revenue Officer »

Benchmark Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:28
07/22/19
07/22
17:28
07/22/19
17:28
Periodicals
Apple may pay $1B or more for Intel patents, staff in chip unit deal, WSJ says »

Apple (AAPL) is in…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

ATVI

Activision Blizzard

$45.57

0.43 (0.95%)

17:26
07/22/19
07/22
17:26
07/22/19
17:26
Hot Stocks
Blizzard co-founder Frank Pearce departing after 28 years »

One of the founders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 05

    Sep

NBSE

NeuBase Therapeutics

$3.55

-0.58 (-14.04%)

17:25
07/22/19
07/22
17:25
07/22/19
17:25
Hot Stocks
Carnegie Mellon reports 5.5% passive stake in NeuBase Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

17:23
07/22/19
07/22
17:23
07/22/19
17:23
Downgrade
Cadence Bancorp rating change  »

Cadence Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 06

    Aug

  • 26

    Aug

  • 23

    Sep

CAL

Caleres

$18.27

0.27 (1.50%)

17:22
07/22/19
07/22
17:22
07/22/19
17:22
Hot Stocks
Caleres, Veronica Beard announce exclusive footwear partnership »

Caleres and Veronica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:22
07/22/19
07/22
17:22
07/22/19
17:22
Periodicals
Breaking Periodicals news story on Apple, Intel »

Apple in advanced talks…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

EFSC

Enterprise Financial

$39.39

-0.58 (-1.45%)

17:19
07/22/19
07/22
17:19
07/22/19
17:19
Earnings
Enterprise Financial reports Q2 EPS 98c, consensus 93c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

TTEC

TTEC Holdings

$47.31

0.04 (0.08%)

17:19
07/22/19
07/22
17:19
07/22/19
17:19
Syndicate
Breaking Syndicate news story on TTEC Holdings »

TTEC Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TTEC

TTEC Holdings

$47.31

0.04 (0.08%)

17:18
07/22/19
07/22
17:18
07/22/19
17:18
Syndicate
Breaking Syndicate news story on TTEC Holdings »

TTEC Holdings files $350M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

VBTX

Veritex

$25.67

-0.44 (-1.69%)

17:17
07/22/19
07/22
17:17
07/22/19
17:17
Earnings
Veritex reports Q2 EPS 59c, consensus 62c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

WM

Waste Management

$117.15

0.39 (0.33%)

17:12
07/22/19
07/22
17:12
07/22/19
17:12
Initiation
Waste Management initiated  »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

IBTX

Independent Bank

$55.08

-1.08 (-1.92%)

17:05
07/22/19
07/22
17:05
07/22/19
17:05
Earnings
Independent Bank reports Q2 adjusted EPS $1.22, consensus $1.27 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

RNST

Renasant

$34.10

-0.49 (-1.42%)

17:04
07/22/19
07/22
17:04
07/22/19
17:04
Earnings
Renasant reports Q2 EPS 80c with items, consensus 81c »

Reports Q2 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

17:03
07/22/19
07/22
17:03
07/22/19
17:03
Hot Stocks
Steel Dynamics announces planned new flat roll steel mill site selection »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Brown & Brown reports Q2 organic revenue up 3.9% »

Reports Q2 EBITDA margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAE

Haemonetics

$122.44

0.35 (0.29%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Haemonetics updates financial reporting segments »

Haemonetics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 05

    Sep

  • 09

    Sep

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:01
07/22/19
07/22
17:01
07/22/19
17:01
Earnings
Brown & Brown reports Q2 adjusted EPS 32c, consensus 28c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DLX

Deluxe

$41.95

0.41 (0.99%)

17:00
07/22/19
07/22
17:00
07/22/19
17:00
Hot Stocks
Deluxe names Chris Thomas chief revenue officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 19

    Sep

GE

General Electric

$10.22

0.18 (1.79%)

, AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

16:57
07/22/19
07/22
16:57
07/22/19
16:57
Hot Stocks
Avalon GloboCare and GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

GE

General Electric

$10.22

0.18 (1.79%)

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:55
07/22/19
07/22
16:55
07/22/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Viveve 

Viveve trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.